MASLD prevalence, incidence and global aspects
Sarah H Wild, Jeffrey V Lazarus, C Wendy Spearman, Ponsiano Ocama, Josh Bilson, Xiao-Dong Zhou, Ming-Hua Zheng, Christopher D Byrne · 2026
Read MASLD prevalence, incidence and global aspects by Sarah H Wild, Jeffrey V Lazarus, C Wendy Spearman, Ponsiano Ocama, Josh Bilson, Xiao-Dong Zhou, Ming-Hua Zheng, Christopher D Byrne (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13627207.txt.
Description
Sarah Wild and co-authors review the worldwide burden of fatty liver disease tied to metabolic problems, known as MASLD, in a 2026 paper. The disease has become inseparable from the global epidemics of obesity and type 2 diabetes, which drive its causes and its outcomes. The review gathers estimates of how common it is, how fast new cases arise, and what it costs in disability and lost years of life.
Estimates vary widely between populations. The authors focus on sub-Saharan Africa and the Asia Pacific, where populations are growing fast and disease patterns are shifting from infections toward long-term conditions. They weigh how income, unfair systems, care access, and food environments shape who gets the disease and who gets treated. The paper closes with chances to make prevention, diagnosis, and treatment fairer worldwide.
Catalog record
| CREATOR | Sarah H Wild, Jeffrey V Lazarus, C Wendy Spearman, Ponsiano Ocama, Josh Bilson, Xiao-Dong Zhou, Ming-Hua Zheng, Christopher D Byrne |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |